Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
BASEL, Switzerland - Novartis announced today that the European Commission (EC) granted a Marketing Authorization for Menveo® (Meningococcal Group A, C, W135 and Y conjugate vaccine) in all 27 Europea...
read more
Prometheus and Bayer Schering Pharma to apply novel diagnostic platform to oncology therapeutic candidates
SAN DIEGO - Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma ...
read more
Roche uniquely positioned to deliver long-term growth, leading late-stage pipeline and innovation strategy presented at investor conference
Roche (SIX: RO, ROG; OTCQX: RHHBY) is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervo...
read more
GE Healthcare and Brainlab working to advance integrated surgical suite solutions
WAUKESHA, WISCONSIN – GE Healthcare, a business unit of General Electric Corp. (NYSE:GE), announced today that it has signed a joint development and marketing agreement with BrainLAB AG, Munich, Germa...
read more
Bayer CropScience and CSIRO expand research cooperation to assess the system-wide environmental impact of new crops
MONHEIM – Bayer CropScience and the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national research agency, are expanding their collaboration to assess the sustaina...
read more
GE Healthcare announces new compatibility for Fractional Flow Reserve (FFR) evaluation with the Mac-Lab® XT and XTi hemodynamic recording systems
WAUKESHA, WISCONSIN - GE Healthcare, the $17 billion medical technology division of General Electric Company (NYSE:GE), today announced the Mac-Lab’s validation of compatibility with the Volcano's Sm...
read more
Rhenovia Pharma among the 75 projects of national poles of competitiveness
Under the ninth call for proposals launched October 20, 2009, 75 collaborative R & D from 52 clusters were selected from 226 submissions.
read more
Huntsman announces successful turnaround and inspection of its Port Neches, TX facility
THE WOODLANDS, Texas - Huntsman Corporation (NYSE: HUN) today announced the successful completion of the turnaround and inspection of its PO/MTBE facility in Port Neches, TX.
read more
Drug giants lag where sales boom, study says
The leading drug makers need to move quickly to adapt to a new world order in which some emerging markets are set to overtake some established national markets in pharmaceutical sales, according to a ...
read more
Statement from Eli Lilly and Company regarding stolen company products from Enfield, Connecticut Distribution Operations
INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 1...
read more
|